Scaling new heights in the fight against heart disease
Founded by leading cardiovascular scientists, our team has the tenacity to pursue our ultimate peak – changing the treatment paradigm for heart disease, and in doing so improving and extending the lives of millions of individuals and families fighting this debilitating disease.
We are a biotechnology company committed to a bold mission: to discover, design, develop and deliver curative therapies that address the underlying drivers of heart disease.
We are revolutionizing the treatment of heart disease through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine.
LATEST NEWS
Tenaya Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
Received State Licensing to Enable cGMP Manufacturing of Drug Product TN-201 and TN-301 IND Submissions on Track for Second Half 2022 Presented Preclinical Data for Multiple Pipeline Programs and Capsid Engineering Efforts SOUTH SAN FRANCISCO, Calif., Aug.
Read MoreGenetic Engineering & Biotechnology News: Tenaya Makes Manufacturing Modular
In this article for GEN, author Mike May interviews Tenaya’s CTO, Kee-Hong Kim, for insights into the decisions and technology that went into the design of our Genetic Medicines Manufacturing Center in Union City, CA. Read More
Read MoreFierce Biotech: Tenaya tackles genetic heart condition after thorough screening process nails down target
Writing for Fierce Biotech, reporter Max Bayer summarizes Tenaya’s preclinical study for dilated cardiomyopathy published in July 2022. The study identified the HDAC6 inhibitor as a target for the potential treatment of DCM. Read More
Read MoreJOIN OUR TEAM
Are you ambitious, driven, energized by scientific innovation and committed to making a difference for patients suffering from heart disease? Do you value a culture grounded in science and collaboration? Our team combines deep biological insights, sophisticated drug development technologies and a boundless determination to change the future for the millions of people affected by heart disease.
